Zimmer clears EU antitrust hurdle for Biomet merge but must drop knee, elbow units
This article was originally published in Clinica
Executive Summary
Zimmer’s proposed $13.35bn acquisition of Biomet has got the green light from EU antitrust authorities, on condition that the company divests three businesses to improve competitiveness across the European Economic Area.